Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.

MLA

Das, A., et al. “Characterisation of the Gene Encoding Type II DNA Topoisomerase from Leishmania Donovani: A Key Molecular Target in Antileishmanial Therapy.” Nucleic Acids Research, vol. 29, no. 9, May 2001, pp. 1844–51. EBSCOhost, https://doi.org/10.1093/nar/29.9.1844.

APA

Das, A., Dasgupta, A., Sharma, S., Ghosh, M., Sengupta, T., Bandopadhyay, S., & Majumder, H. K. (2001). Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy. Nucleic Acids Research, 29(9), 1844–1851. https://doi.org/10.1093/nar/29.9.1844

Chicago

Das, A, A Dasgupta, S Sharma, M Ghosh, T Sengupta, S Bandopadhyay, and H K Majumder. 2001. “Characterisation of the Gene Encoding Type II DNA Topoisomerase from Leishmania Donovani: A Key Molecular Target in Antileishmanial Therapy.” Nucleic Acids Research 29 (9): 1844–51. doi:10.1093/nar/29.9.1844.